Zobrazeno 1 - 10
of 26
pro vyhledávání: '"Eleftherios Kampletsas"'
Autor:
Melina Yerolatsite, Nanteznta Torounidou, Anna-Lea Amylidi, Fani Kapoulitsa, Eleftherios Kampletsas, George Zarkavelis, Davide Mauri
Publikováno v:
Case Reports in Oncology, Vol 17, Iss 1, Pp 417-422 (2024)
Introduction: The introduction of immune checkpoint inhibitors (ICIs) has opened a new chapter in cancer treatment. Nevertheless, their use may result in immune-related adverse events (irAEs) with multifactorial determinants, complex mechanisms, and
Externí odkaz:
https://doaj.org/article/2d965df517914da59828fbf9df33838d
Autor:
Anna Lea Amylidi, Aristeidis Gogadis, Melina Yerolatsite, George Zarkavelis, Nanteznta Torounidou, Varvara Keramisanou, Eleftherios Kampletsas, Davide Mauri
Publikováno v:
Current Oncology, Vol 30, Iss 12, Pp 10509-10518 (2023)
Immune checkpoint inhibitors, such as anti-PD-1 and anti-CTLA-4 inhibitors, have become the standard of care for many cancer types. However, they induce immune-related adverse events (irAEs), including neurotoxicity and hypophysitis. The incidence an
Externí odkaz:
https://doaj.org/article/0f91f00460cc465c94fd9ce28b23b0ff
Autor:
Aikaterini Tsantikidi, Eirini Papadopoulou, Vasiliki Metaxa-Mariatou, George Kapetsis, Georgios Tsaousis, Angeliki Meintani, Chrysiida Florou-Chatzigiannidou, Maria Gazouli, Christos Papadimitriou, Eleni Timotheadou, Athanasios Kotsakis, Anastasios Boutis, Ioannis Boukovinas, Eleftherios Kampletsas, Loukas Kontovinis, Elena Fountzilas, Charalampos Andreadis, Charisios Karanikiotis, Dimitrios Filippou, Georgios Theodoropoulos, Mustafa Özdoğan, George Nasioulas
Publikováno v:
Diagnostics, Vol 13, Iss 18, p 2962 (2023)
Several tumor types have been efficiently treated with PARP inhibitors (PARPis), which are now approved for the treatment of ovarian, breast, prostate, and pancreatic cancers. The BRCA1/2 genes and mutations in many additional genes involved in the H
Externí odkaz:
https://doaj.org/article/d2ca410e5d3c42a1ae693c3b0eb61e8b
Autor:
Davide Mauri, Eleftherios Kampletsas, George Smyris, Lampriani Tsali, Periklis Tsekeris, Haralampos Harissis, Konstantinos Kamposioras, Maria Tolia, Thomas Hyphantis, Panagiotis Ntellas, Ioanna Gazouli, Georgios Zarkavelis, Leonidas Mavroeidis, Anna-Lea Amylidi, Nanteznta Torounidou, Aristeidis Gogadis, Joanna Nixon
Publikováno v:
Palliative Medicine Reports, Vol 2, Iss 1, Pp 365-368 (2021)
Background: Upon the onset of a debilitating rapidly evolving condition (such as cancer or a rapidly progressing myopathy, neuropathy, respiratory disease, or a severe traumatic injury), individuals have limited time to find a new home or make radica
Externí odkaz:
https://doaj.org/article/f8be624a9a43466e9ce74eb654f969e5
Autor:
Ioanna Gazouli, Stavros Tsampalas, Ioannis Tsimaris, Georgios Zarkavelis, Nikolaos Grivas, Eleftherios Kampletsas, Alexandra Papadaki, Leonidas Mavroeidis, Panagiotis Ntellas, Stefania Gkoura, Lampriani Tsali, Anna-Lea Amylidi, Maria Smaragdi Vlachou, Davide Mauri
Publikováno v:
Urology Annals, Vol 13, Iss 1, Pp 86-88 (2021)
Testicular metastases from ureteral carcinoma are rare and they are generally mimic orchiepididymitis. For this reason, these are associated to misleading diagnoses and cancer treatment delay. We believe that both timing and knowledge of genital bloo
Externí odkaz:
https://doaj.org/article/e1685abd1ae546a481862f5781d9df54
Autor:
Davide Mauri, Georgia Zafeiri, Melina Yerolatsite, Lampriani Tsali, Georgios Zarkavelis, Anna Tsiara, Nikolaos P. Polyzos, Antonis Valachis, Konastantina Kalopita, Eleftherios Kampletsas, Alexandra Papadaki, Evangelia Peponi, Fani Kapoulitsa, Panagiotis Filis, Georgios Pentheroudakis
Publikováno v:
Contemporary Oncology, Vol 23, Iss 2, Pp 100-109 (2019)
Externí odkaz:
https://doaj.org/article/fa3ea4100a1942249d99b77ace19b69c
Autor:
Davide Mauri, Ioanna Gazouli, Georgios Zarkavelis, Alexandra Papadaki, Leonidas Mavroeidis, Stefania Gkoura, Panagiotis Ntellas, Anna-Lea Amylidi, Lampriani Tsali, Eleftherios Kampletsas
Publikováno v:
Frontiers in Endocrinology, Vol 11 (2020)
As the incidence of malignancies in young adults is increasing, fertility preservation in cancer survivors arises as a major concern. Especially among female cancer patients, pregnancy rates are estimated to be 40% lower compared to women of the same
Externí odkaz:
https://doaj.org/article/3be5cf09f72844b295dd13bdcfa62938
Autor:
George Pentheroudakis, Eirini Papadopoulou, George Nasioulas, Anastasia Kougioumtzi, Panagiotis Ntellas, Eleftherios Kampletsas
Publikováno v:
ESMO Open, Vol 4, Iss 5 (2019)
Background: Non-small-cell lung cancer (NSCLC) is recognised as a particularly heterogeneous disease, encompassing a wide spectrum of distinct molecular subtypes. With increased understanding of disease biology and mechanisms of progression, treatmen
Externí odkaz:
https://doaj.org/article/bdb08c5b0362432e8c948447e40c74db
Autor:
George Zarkavelis, Aristomenes Kollas, Eleftherios Kampletsas, Vasilis Vasiliou, Evripides Kaltsonoudis, Alexandros Drosos, Hussein Khaled, Nicholas Pavlidis
Publikováno v:
Journal of Advanced Research, Vol 7, Iss 5, Pp 719-726 (2016)
Subacute cutaneous lupus erythematosus (SCLE) is characterized by particular cutaneous manifestations such as non-scaring plaques mainly in sunlight exposed parts of the body along with specific serum autoantibodies (i.e. antinuclear antibodies (ANA)
Externí odkaz:
https://doaj.org/article/35de3f570d85444badbe2b6f28860fad
Autor:
ANGELA APESSOS, KONSTANTINOS AGIANNITOPOULOS, GEORGIA PEPE, GEORGIOS N. TSAOUSIS, PANAGIOTA PITTA, CHRYSANTHI BILI, LINA FLORENTIN, EMMANOUEL SALOUSTROS, ELEFTHERIOS KAMPLETSAS, DIMITRIOS TRYFONOPOULOS, NIKOLAOS TSOUKALAS, EVANGELOS BOURNAKIS, FLORA ZAGOURI, ATHANASSIOS KOTSAKIS, ANNA KOUMARIANOU, IPPOKRATIS KORANTZIS, IOANNIS BOUKOVINAS, GEORGE LYPAS, GEORGIOS FOUNTZILAS, VASILIKI MICHALAKI, SPYRIDON XYNOGALOS, HELENA LINARDOU, EIRINI PAPADOPOULOU, GEORGE NASIOULAS, VASSILIS GEORGOULIAS
Publikováno v:
Anticancer research. 42(12)
Male breast cancer (MBC) is a very rare disorder affecting approximately 1 in 833 men. Genetic predisposition is one of the most important risk factors of MBC with BRCA2 being the most commonly mutated gene in males diagnosed with breast cancer. Howe
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::a852445b90d523e02fa54397b3d744e8
https://pubmed.ncbi.nlm.nih.gov/36456130
https://pubmed.ncbi.nlm.nih.gov/36456130